ViCardia Therapeutics, Inc. funding
ViCardia Therapeutics, Inc., a biotechnology company based in San Francisco, CA, filed a Form D with the SEC on May 21, 2026 and reported $700K raised.
Amount raised$700K
Offering size$700K
Filed with the SECMay 21, 2026
First saleMay 19, 2026
IndustryBiotechnology
SecuritiesEquity
LocationSan Francisco, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment$10K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed May 21
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology